(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA., The Lancet ., doi : 10.1016/S0140-6736(23)01053-X.
Tamoxifen chemotherapy
As with all research peptides, proper storage, handling, and compliance with research-use-only guidelines are essential.
Recently presented at the ILADS medical conference, human clinical research demonstrated that Tri-Fortify promotes healthy red blood cell glutathione levels & natural killer cell function.* With absorption into red blood cells the goal of IV and oral glutathione treatment, Tri-Fortify provides the doctor an efficacious oral glutathione which may be prescribed on its own or to be used on days when IV treatment is not available.* Tri-Fortify provides the preferred reduced L-glutathione, the major intracellular antioxidant essential for detoxification in the body, plus vitamin C, in an absorbable liposomal delivery system
